DK2177512T3 - S1P1-bindingshæmmer - Google Patents

S1P1-bindingshæmmer

Info

Publication number: DK2177512T3
Authority: DK; Denmark
Prior art keywords: group; nitrogen atom; group represented; optionally substituted; atom
Prior art date: 2007-08-01

Application number

DK08792064.1T

Other languages

English (en)

Inventor

Naoya Ono

Fumiyasu Shiozawa

Tetsuya Yabuuchi

Hironori Katakai

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-01

Filing date

2008-08-01

Publication date

2012-06-18

2008-08-01 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2012-06-18 Application granted granted Critical

2012-06-18 Publication of DK2177512T3 publication Critical patent/DK2177512T3/da

Links

102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 title abstract 2
101710155454 Sphingosine 1-phosphate receptor 1 Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
229910052757 nitrogen Inorganic materials 0.000 abstract 3
125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
206010012438 Dermatitis atopic Diseases 0.000 abstract 1
101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
208000017442 Retinal disease Diseases 0.000 abstract 1
206010038923 Retinopathy Diseases 0.000 abstract 1
206010064930 age-related macular degeneration Diseases 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
201000008937 atopic dermatitis Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
208000002780 macular degeneration Diseases 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
201000008482 osteoarthritis Diseases 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
238000002054 transplantation Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

DK08792064.1T 2007-08-01 2008-08-01 S1P1-bindingshæmmer DK2177512T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007201274		2007-08-01
PCT/JP2008/063851 WO2009017219A1 (ja)	2007-08-01	2008-08-01	Ｓ１ｐ1結合阻害物質

Publications (1)

Publication Number	Publication Date
DK2177512T3 true DK2177512T3 (da)	2012-06-18

Family

ID=40304448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08792064.1T DK2177512T3 (da)	2007-08-01	2008-08-01	S1P1-bindingshæmmer

Country Status (16)

Country	Link
US (1)	US8048898B2 (da)
EP (1)	EP2177512B1 (da)
JP (1)	JP5311057B2 (da)
CN (1)	CN101790517B (da)
AT (1)	ATE554070T1 (da)
CY (1)	CY1113057T1 (da)
DK (1)	DK2177512T3 (da)
ES (1)	ES2382697T3 (da)
HK (1)	HK1143591A1 (da)
HR (1)	HRP20120363T1 (da)
PL (1)	PL2177512T3 (da)
PT (1)	PT2177512E (da)
RS (1)	RS52368B (da)
RU (1)	RU2468009C2 (da)
SI (1)	SI2177512T1 (da)
WO (1)	WO2009017219A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201118876D0 (en) *	2011-11-01	2011-12-14	Astex Therapeutics Ltd	Pharmaceutical compounds
SG11202006255UA (en)	2018-02-02	2020-07-29	Univ Kyoto	Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05194412A (ja)	1991-12-28	1993-08-03	Advance Co Ltd	ジアゾリン化合物
GB9202791D0 (en) *	1992-02-11	1992-03-25	British Bio Technology	Compounds
DK0786455T3 (da)	1994-09-26	2004-03-29	Shionogi & Co	Imidazolderivater
AU2001246999A1 (en)	2000-04-06	2001-10-23	Astrazeneca Ab	New neurokinin antagonists for use as medicaments
US20020110604A1 (en)	2000-08-11	2002-08-15	Ashni Naturaceuticals, Inc.	Composition exhibiting synergistic antioxidant activity
JP2004507552A (ja)	2000-08-31	2004-03-11	メルク　エンド　カムパニー　インコーポレーテッド	免疫調節剤としてのリン酸誘導体
JP2002212070A (ja)	2001-01-24	2002-07-31	Ono Pharmaceut Co Ltd	アスパラギン酸誘導体を有効成分として含有するスフィンゴシン−１−リン酸拮抗剤
AU2002238855B2 (en) *	2001-03-12	2007-12-06	Ono Pharmaceutical Co., Ltd.	N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
JP2002332278A (ja)	2001-05-08	2002-11-22	Human Science Shinko Zaidan	Ｅｄｇ受容体拮抗作用を有する複素環誘導体
DE60230262D1 (de)	2001-05-10	2009-01-22	Ono Pharmaceutical Co	Carbonsäurederivate und diese als wirkstoff enthaltende arzneimittel
KR20040015716A (ko) *	2001-05-22	2004-02-19	뉴로젠 코포레이션	Ｃｒｆ1 조절자로서의 5-치환된-2-아릴피리딘
GB0113524D0 (en)	2001-06-04	2001-07-25	Hoffmann La Roche	Pyrazole derivatives
DE10130397A1 (de)	2001-06-23	2003-01-09	Bayer Cropscience Gmbh	Herbizide substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbzide und Pflanzenwachstumsregulatoren
RU2309148C2 (ru) *	2001-09-27	2007-10-27	Юниверсите Де Льеж	Производные пиридинсульфонамида, фармацевтическая композиция на их основе и применение
JP4035759B2 (ja)	2001-11-06	2008-01-23	独立行政法人産業技術総合研究所	アミノアルコールリン酸化合物、製造方法、及びその利用方法
US7309721B2 (en)	2002-03-01	2007-12-18	Merck + Co., Inc.	Aminoalkylphosphonates and related compounds as Edg receptor agonists
WO2003074008A2 (en)	2002-03-01	2003-09-12	Merck & Co., Inc.	Aminoalkylphosphonates and related compounds as edg receptor agonists
CA2483594C (en)	2002-05-16	2011-02-15	Novartis Ag	Use of edg receptor binding agents in cancer
JP2005533058A (ja)	2002-06-17	2005-11-04	メルク　エンド　カムパニー　インコーポレーテッド	Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
EP1539674A1 (en)	2002-09-13	2005-06-15	Novartis AG	Amino-propanol derivatives
JP4516430B2 (ja)	2002-12-20	2010-08-04	メルク・シャープ・エンド・ドーム・コーポレイション	１−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
TW200423930A (en)	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
JP2006522825A (ja) *	2003-04-10	2006-10-05	アムジェンインコーポレイテッド	ブラジキニンレセプター親和性を有する二環式化合物およびその薬学的組成物
JP2006522745A (ja)	2003-04-11	2006-10-05	ノボ　ノルディスク　アクティーゼルスカブ	置換１，２，４−トリアゾールの薬学的使用
WO2004103279A2 (en)	2003-05-15	2004-12-02	Merck & Co., Inc.	3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
WO2005058848A1 (en)	2003-12-17	2005-06-30	Merck & Co., Inc.	(3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
WO2005123677A1 (en)	2004-06-16	2005-12-29	Actelion Pharmaceuticals Ltd	4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
CN1993333B (zh)	2004-08-04	2012-08-01	大正制药株式会社	***衍生物
DE102005012482A1 (de) *	2005-03-16	2006-09-21	Basf Ag	Verfahren zur Herstellung von Polyoxymethylenen
US20080161187A1 (en)	2005-03-16	2008-07-03	Basf Aktiengesellschaft	Biphenyl-N-(4-Pyridyl) Methylsulfonamides
BRPI0615133A2 (pt) *	2005-08-23	2011-05-03	Irm Llc	compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
TW200736234A (en) *	2006-01-17	2007-10-01	Astrazeneca Ab	Chemical compounds
EP1988083B1 (en)	2006-02-03	2014-04-02	Taisho Pharmaceutical Co., Ltd.	Triazole derivative
EP1988081B1 (en)	2006-02-06	2012-10-17	Taisho Pharmaceutical Co., Ltd	Binding inhibitor of sphingosine-1-phosphate
US8097644B2 (en)	2006-03-28	2012-01-17	Allergan, Inc.	Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
CN101426770A (zh)	2006-04-21	2009-05-06	阿斯利康(瑞典)有限公司	用作edg-1拮抗剂的咪唑衍生物
JP2009534365A (ja)	2006-04-21	2009-09-24	アストラゼネカアクチボラグ	Ａｄｇ受容体修飾物質として有用なスルホンアミド化合物

2008
- 2008-08-01 JP JP2009525458A patent/JP5311057B2/ja not_active Expired - Fee Related
- 2008-08-01 US US12/671,401 patent/US8048898B2/en not_active Expired - Fee Related
- 2008-08-01 EP EP08792064A patent/EP2177512B1/en active Active
- 2008-08-01 RS RS20120266A patent/RS52368B/en unknown
- 2008-08-01 WO PCT/JP2008/063851 patent/WO2009017219A1/ja active Application Filing
- 2008-08-01 CN CN2008801013035A patent/CN101790517B/zh not_active Expired - Fee Related
- 2008-08-01 DK DK08792064.1T patent/DK2177512T3/da active
- 2008-08-01 PT PT08792064T patent/PT2177512E/pt unknown
- 2008-08-01 RU RU2010107211/04A patent/RU2468009C2/ru not_active IP Right Cessation
- 2008-08-01 SI SI200830618T patent/SI2177512T1/sl unknown
- 2008-08-01 PL PL08792064T patent/PL2177512T3/pl unknown
- 2008-08-01 AT AT08792064T patent/ATE554070T1/de active
- 2008-08-01 ES ES08792064T patent/ES2382697T3/es active Active
2010
- 2010-10-28 HK HK10110155.8A patent/HK1143591A1/xx not_active IP Right Cessation
2012
- 2012-04-25 HR HRP20120363AT patent/HRP20120363T1/hr unknown
- 2012-07-04 CY CY20121100601T patent/CY1113057T1/el unknown

Also Published As

Publication number	Publication date
PT2177512E (pt)	2012-05-07
US8048898B2 (en)	2011-11-01
HK1143591A1 (en)	2011-01-07
JPWO2009017219A1 (ja)	2010-10-21
SI2177512T1 (sl)	2012-06-29
RU2010107211A (ru)	2011-09-10
EP2177512A1 (en)	2010-04-21
JP5311057B2 (ja)	2013-10-09
EP2177512B1 (en)	2012-04-18
RU2468009C2 (ru)	2012-11-27
ES2382697T3 (es)	2012-06-12
EP2177512A4 (en)	2011-01-05
CN101790517A (zh)	2010-07-28
US20100234594A1 (en)	2010-09-16
CY1113057T1 (el)	2016-04-13
PL2177512T3 (pl)	2012-09-28
CN101790517B (zh)	2013-08-21
HRP20120363T1 (hr)	2012-05-31
WO2009017219A1 (ja)	2009-02-05
ATE554070T1 (de)	2012-05-15
RS52368B (en)	2012-12-31

Publication	Publication Date	Title
EA017861B9 (ru)	2014-05-30	Способ получения 4-оксохинолинового соединения
WO2008126933A3 (en)	2008-12-31	Process for producing pesticidal benzamide compounds
MY168201A (en)	2018-10-15	Agricultural And Horticultural Fungicidal Composition
EA201000413A1 (ru)	2010-06-30	Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида
MX2009009492A (es)	2009-09-15	Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas.
WO2008108378A3 (en)	2008-12-04	Bicyclic oxomorpholine derivative
WO2010051926A8 (de)	2011-04-07	Neue halogen-substituierte verbindungen
ATE550334T1 (de)	2012-04-15	N-pyridylpiperidinverbindung, verfahren zu ihrer herstellung und schädlingsbekämpfungsmittel
JO2853B1 (en)	2015-03-15	Sulfonamides as TRPM8 organizations
MX2009011733A (es)	2009-11-10	Utilizacion de piridin-2-oxi-3-carboxamidas como antidotos.
EA201000269A1 (ru)	2010-08-30	Новые гербициды
MX2010001364A (es)	2010-03-01	Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
RS53613B1 (en)	2015-04-30	COMPOUNDS, COMPOSITIONS, AND PROCEDURES FOR TREATMENT OF BETA-AMYLOID DISEASES AND SYNUCLEINOPATHY
WO2009028280A1 (ja)	2009-03-05	ピラゾールカルボン酸誘導体及びその製造方法、並びに殺菌剤
WO2008146914A1 (ja)	2008-12-04	複素環化合物
MX2009008509A (es)	2009-08-20	Compuesto de anillo puenteado-aza.
EA201270359A1 (ru)	2012-09-28	Терапевтическое средство от расстройств настроения
EA201100920A1 (ru)	2012-01-30	Новые гербициды
NO20081804L (no)	2008-07-03	Pyrazolforbindelser egnet til behandling av inflammasjon
MX2010001566A (es)	2010-03-15	Derivado de aminopirazolamida.
ATE500212T1 (de)	2011-03-15	Bisphenol monoester
WO2008136378A1 (ja)	2008-11-13	新規なスルホンアミド誘導体またはその塩
UA111950C2 (uk)	2016-07-11	Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну
UA96149C2 (en)	2011-10-10	Method for producing 4-oxoquinoline compound
EA201000394A1 (ru)	2010-08-30	Гербицидные композиции